Sirio Pharma - Asset Resilience Ratio

Latest as of June 2025: 0.01%

Sirio Pharma (300791) has an Asset Resilience Ratio of 0.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300791 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥405.30K
≈ $59.31K USD Cash + Short-term Investments

Total Assets

CN¥5.74 Billion
≈ $839.26 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Sirio Pharma's Asset Resilience Ratio has changed over time. See 300791 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Sirio Pharma's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sirio Pharma (300791) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥405.30K 0.01%
Total Liquid Assets CN¥405.30K 0.01%

Asset Resilience Insights

  • Limited Liquidity: Sirio Pharma maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sirio Pharma Industry Peers by Asset Resilience Ratio

Compare Sirio Pharma's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Orkla ASA
OL:ORK
Packaged Foods 4.19%
New Hope Dairy Co Ltd
SHE:002946
Packaged Foods 2.26%
Yankershop Food Co Ltd
SHE:002847
Packaged Foods 4.97%
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
SHG:605016
Packaged Foods 6.41%
Yantai China Pet Foods Co Ltd
SHE:002891
Packaged Foods 0.35%
Xinjiang Guannong Fruit & Antler Group Co Ltd
SHG:600251
Packaged Foods 5.13%
Xiamen Kingdomway Group Co
SHE:002626
Packaged Foods 4.11%
Zhejiang Huatong Meat Products Co Ltd
SHE:002840
Packaged Foods 3.78%

Annual Asset Resilience Ratio for Sirio Pharma (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Sirio Pharma.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.10% CN¥115.20 Million
≈ $16.86 Million
CN¥5.49 Billion
≈ $802.78 Million
-1.76pp
2023-12-31 3.86% CN¥200.66 Million
≈ $29.36 Million
CN¥5.20 Billion
≈ $760.30 Million
+1.97pp
2022-12-31 1.89% CN¥79.13 Million
≈ $11.58 Million
CN¥4.19 Billion
≈ $612.52 Million
-12.00pp
2021-12-31 13.89% CN¥530.77 Million
≈ $77.67 Million
CN¥3.82 Billion
≈ $559.00 Million
-3.98pp
2020-12-31 17.87% CN¥473.49 Million
≈ $69.29 Million
CN¥2.65 Billion
≈ $387.73 Million
--
pp = percentage points

About Sirio Pharma

SHE:300791 China Packaged Foods
Market Cap
$876.92 Million
CN¥5.99 Billion CNY
Market Cap Rank
#9714 Global
#2726 in China
Share Price
CN¥19.50
Change (1 day)
+0.36%
52-Week Range
CN¥18.79 - CN¥31.81
All Time High
CN¥57.47
About

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. … Read more